Rifater 50 mg/300 mg/120 mg Tablets Ierland - Engels - HPRA (Health Products Regulatory Authority)

rifater 50 mg/300 mg/120 mg tablets

sanofi-aventis ireland limited t/a sanofi - isoniazid; pyrazinamide; rifampicin - tablet - 50 /300 /120 milligram(s) - combinations of drugs for treatment of tuberculosis; rifampicin, pyrazinamide and isoniazid

Rifampicin 60mg-Isoniazid 30mg Tablets tablets dispersible Armenië - Engels - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

rifampicin 60mg-isoniazid 30mg tablets tablets dispersible

lupin limited - rifampicin, isoniazid - tablets dispersible - 60mg+ 30mg

Rifampicin Isoniazid Pyrazinamide Ethambutol hydrochloride tablets film-coated Armenië - Engels - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

rifampicin isoniazid pyrazinamide ethambutol hydrochloride tablets film-coated

lupin limited - rifampicin, isoniazid, pyrazinamide, ethambutol (ethambutol hydrochloride) - tablets film-coated - 150mg+ 75mg+ 400mg+ 275mg

Rifampicin Isoniazid tablets film-coated Armenië - Engels - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

rifampicin isoniazid tablets film-coated

lupin limited - rifampicin, isoniazid - tablets film-coated - 150mg+ 75mg

RIMYCIN 300 rifampicin 300 mg capsule bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

rimycin 300 rifampicin 300 mg capsule bottle

alphapharm pty ltd - rifampicin, quantity: 300 mg - capsule, hard - excipient ingredients: purified talc; gelatin; purified water; ascorbic acid; magnesium stearate; brilliant blue fcf; colloidal anhydrous silica; sodium lauryl sulfate; titanium dioxide; erythrosine; lactose monohydrate - indications as at 5 december 2001 : tuberculosis. in the initial treatment and in retreatment of patients with tuberculosis, rifampicin must be used in conjunction with at least one other antituberculosis drug. leprosy - in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the non-infectious state which may be expected to occur in three to four months of treatment. - as an alternative drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other anti-leprosy drugs. - as an alternative drug in all those patients having true drug allergy to the more commonly used anti-leprosy drugs.,meningococcal disease prophylaxis of meningococcal disease in close contacts of known cases and in carriers (rifampicin is not indicated for the treatment of meningococcal infections).,haemophilus influenzae prophylaxis of household contacts of patients with haemophilus influenzae type b.,buruli ulcer for the treatment of myc

RIMYCIN 150 rifampicin 150 mg capsule bottle Australië - Engels - Department of Health (Therapeutic Goods Administration)

rimycin 150 rifampicin 150 mg capsule bottle

alphapharm pty ltd - rifampicin, quantity: 150 mg - capsule, hard - excipient ingredients: ascorbic acid; magnesium stearate; iron oxide red; colloidal anhydrous silica; purified water; lactose monohydrate; brilliant blue fcf; purified talc; iron oxide yellow; erythrosine; gelatin; sodium lauryl sulfate; titanium dioxide - indications as at 5 december 2001 : tuberculosis. in the initial treatment and in retreatment of patients with tuberculosis, rifampicin must be used in conjunction with at least one other antituberculosis drug. leprosy - in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the non-infectious state which may be expected to occur in three to four months of treatment. - as an alternative drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other anti-leprosy drugs. - as an alternative drug in all those patients having true drug allergy to the more commonly used anti-leprosy drugs.,meningococcal disease prophylaxis of meningococcal disease in close contacts of known cases and in carriers (rifampicin is not indicated for the treatment of meningococcal infections).,haemophilus influenzae prophylaxis of household contacts of patients with haemophilus influenzae type b.,buruli ulcer for the treatment of myc

Isoniazid Dispersible Tablets 100mg Tanzania - Engels - Tanzania Medicinces & Medical Devices Authority

isoniazid dispersible tablets 100mg

macleods pharmaceuticals limited, india - isoniazid - dispersible tablets - 100

Royce Rifampicin Capsule 300mg Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

royce rifampicin capsule 300mg

royce pharma manufacturing sdn. bhd. - rifampicin -

Royce Rifampicin Capsule 150mg Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

royce rifampicin capsule 150mg

royce pharma manufacturing sdn. bhd. - rifampicin -

Voractiv tablets Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

voractiv tablets

genus pharmaceuticals ltd - ethambutol hydrochloride; pyrazinamide; isoniazid; rifampicin - oral tablet - 275mg ; 400mg ; 75mg ; 150mg